Cellular Goods PLC Grant of Warrants (0110Z)
10 Mayo 2023 - 11:48AM
UK Regulatory
TIDMCBX
RNS Number : 0110Z
Cellular Goods PLC
10 May 2023
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014, as retained as part of
the law of England and Wales. Upon the publication of this
announcement via the Regulatory Information Service, this inside
information is now considered to be in the public domain.
10 May 2023
Cellular Goods PLC
("Cellular Goods" or "the Company")
Grant of Warrants
Cellular Goods (LSE: CBX) a UK-based skincare and wellness
company providing premium consumer products formulated with
lab-produced cannabinoids, announces that it has granted Misha
Sher, the Company's Non-Executive Director, a total of 2,000,000
warrants to subscribe for new ordinary shares of GBP0.001 each
('Warrants'). The Warrants are exercisable at 0. 97 pence per
ordinary share.
One third of the warrants will vest on 10 May 2024 with the
remaining two thirds vesting in 24 equal monthly instalments
thereafter. The Warrants have an exercise period from the date of
grant to 10 May 2028.
Following the issue of the Warrants, the Company has a total of
59,460,000 warrants in issue.
For further information please contact:
Cellular Goods
Darcy Taylor via Tancredi +44 207 887 7633
Chairman and interim CEO
Neil Thapar +44 787 645 5323
Investor Relations
------------------------------
First Sentinel Corporate Finance
------------------------------
Corporate Broker & Advisor
Brian Stockbridge +44 7876 888 011
------------------------------
Novum Securities
------------------------------
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
------------------------------
Tancredi Intelligent Communication
------------------------------
Media Relations
Helen Humphrey
Charlie Hobbs +44 744 922 6720
cellulargoods@tancredigroup.com +44 789 755 7112
------------------------------
About Cellular Goods PLC:
Cellular Goods develops and markets premium quality skincare and
wellness products based on proprietary formulations incorporating
biosynthetic lab-made cannabinoids. Our branded products are
efficacy-led and research-backed and available online in the UK and
US. The Company is incorporated in the UK and listed on the Main
Market of the London Stock Exchange. For more information, visit
www.cellular-goods.com .
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
Details of the person discharging managerial responsibilities
1. / person closely associated
a) Name Misha Sher
------------------------------ ------------------------------------
Reason for the Notification
2.
--------------------------------------------------------------------
a) Position/status N o n-executive director
------------------------------ ------------------------------------
b) Initial notification Initial notification
/ Amendment
------------------------------ ------------------------------------
Details of the issuer, emission allowance market participant,
3. auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Cellular Goods PLC
------------------------------ ------------------------------------
b) LEI 213800IXPX4Z2MKX2U28
------------------------------ ------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
--------------------------------------------------------------------
a) Description of the Ordinary Shares of GBP0.001 each
Financial instrument,
type of instrument
ISIN ISIN: GB00BK964W87
------------------------------ ------------------------------------
b) Nature of the transaction Grant of warrants over 2,000,000
ordinary shares
------------------------------ ------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price 2,000,000
of 0.97 pence Ordinary Shares
per Ordinary
Share
-----------------
------------------------------ ------------------------------------
d) Aggregated information:
* Aggregated volume 2,000,000 Ordinary Shares
Exercise price of 0.97 pence per
Ordinary Share
* Price
------------------------------ ------------------------------------
e) Date of the transaction 10(th) May 2023
------------------------------ ------------------------------------
f) Place of the Transaction Outside a trading venue
------------------------------ ------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHQBLFFXELZBBE
(END) Dow Jones Newswires
May 10, 2023 12:48 ET (16:48 GMT)
Cellular Goods (LSE:CBX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Cellular Goods (LSE:CBX)
Gráfica de Acción Histórica
De May 2023 a May 2024
